Meeder Asset Management Inc. bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 21,778 shares of the company’s stock, valued at approximately $1,141,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. bought a new stake in Astera Labs during the 1st quarter valued at approximately $127,268,000. Price T Rowe Associates Inc. MD acquired a new position in shares of Astera Labs during the first quarter worth approximately $44,514,000. Capital World Investors bought a new stake in shares of Astera Labs in the first quarter valued at approximately $44,514,000. Bamco Inc. NY acquired a new stake in shares of Astera Labs in the first quarter worth $37,095,000. Finally, TimesSquare Capital Management LLC increased its position in Astera Labs by 158,424.1% during the third quarter. TimesSquare Capital Management LLC now owns 321,804 shares of the company’s stock worth $16,859,000 after acquiring an additional 321,601 shares during the period.
Wall Street Analyst Weigh In
ALAB has been the subject of a number of research reports. Roth Mkm increased their price target on shares of Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Craig Hallum increased their target price on shares of Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Barclays boosted their price target on Astera Labs from $70.00 to $87.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Evercore ISI reduced their price objective on Astera Labs from $98.00 to $80.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $94.67.
Insider Buying and Selling
In other news, insider Sanjay Gajendra sold 740,000 shares of the stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $96.59, for a total transaction of $71,476,600.00. Following the sale, the insider now directly owns 775,000 shares of the company’s stock, valued at $74,857,250. This represents a 48.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Stefan A. Dyckerhoff sold 50,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $89.70, for a total transaction of $4,485,000.00. Following the completion of the transaction, the director now owns 129,617 shares of the company’s stock, valued at $11,626,644.90. This trade represents a 27.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,408,458 shares of company stock worth $113,124,841 in the last three months.
Astera Labs Price Performance
Shares of NASDAQ ALAB opened at $95.18 on Wednesday. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $100.09. The business has a fifty day moving average of $66.06 and a two-hundred day moving average of $59.22.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.06. The firm had revenue of $113.10 million during the quarter, compared to the consensus estimate of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm’s quarterly revenue was up 47.1% compared to the same quarter last year. As a group, equities analysts forecast that Astera Labs, Inc. will post -0.45 earnings per share for the current fiscal year.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Recommended Stories
- Five stocks we like better than Astera Labs
- 3 Small Caps With Big Return Potential
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- How to Invest in Small Cap Stocks
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- 3 Stocks to Consider Buying in October
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.